Search
Use the filters to narrow by type of content
Looking for a Publication? Search the bibliography for: publications studying cancer adverse outcome nononcological therapies review food drug
… with a focus on the development of patient-reported outcome (PRO) measurement strategies to best meet the needs … eczema, Alzheimer’s disease, non‒muscle invasive bladder cancer, multiple myeloma, acute myeloid leukemia, acute … and timelines. Ms. Crawford's work has led to articles in publications such as Journal of Medical Economics, Health and …
… patients (pts) with de novo, HR+/HER2− metastatic breast cancer: a SEER-Medicare analysis. Brufsky A, Sandin R, … Session Type and Title: Poster Session – Breast Cancer—Metastatic Session Date and Time: 6/2/2024 9:00 …
Josephine Mauskopf Recognized by ISPOR For Extraordinary Leadership Share on: April 16, 2019 The International Society for Pharmacoeconomics and Outcomes Research ( ISPOR ) announced yesterday that it had recognized Josephine Mauskopf, PhD, Vice …
… treatment resources and improved access for people seeking drug and alcohol treatment in Australia. Prior to joining … peer-reviewed journals including Addiction, Contemporary Drug Problems, Drug and Alcohol Review, Sucht, and Journal of Substance Abuse Treatment. …
… Ames, IA Cassondra Saande, PhD is a Medical Writer in Publications at RTI-HS, where she collaborates with … researchers across therapeutic fields to plan and develop publications highlighting their work. Key therapeutic areas …
… epidemiologic support for the preparation of orphan drug applications and other key regulatory submissions in the …
… data analysis, and development of institutional review board documents. Ms. Milien joined RTI-HS after …
… create reports for regulatory and HTA purposes as well as publications, interactive tools, and models to help you …
… and electronic health data sources. Ms. Hoffman has led drug safety and effectiveness studies across several … the development and validation of claims-based disease and outcome algorithms. Ms. Hoffman has extensive experience … and has served as a reviewer for Pharmacoepidemiology and Drug Safety and other peer-reviewed journals. Ms. Hoffman …
… option to fill the gaps. For example, if we suspect a drug has a rare toxicity after years of being marketed, we …